{
  "id": "a4ddec5f28e5e398",
  "title": "CSL Shares Fall 11% After First-Half Net Profit Misses Estimate",
  "description": "CSL Ltd. shares dropped after the Australian biotech posted an 81% drop in first-half profit, as a new interim chief executive officer takes charge amid asset write-downs, weaker vaccine markets and a years-long slide in investor confidence.",
  "content": "CSL Ltd. shares dropped after the Australian biotech posted an 81% drop in first-half profit, as a new interim chief executive officer takes charge amid asset write-downs, weaker vaccine markets and a years-long slide in investor confidence.",
  "source": "Bloomberg Markets",
  "source_url": "https://www.bloomberg.com/news/articles/2026-02-10/csl-first-half-profit-slumps-highlighting-challenge-for-new-ceo",
  "published_at": "2026-02-10T21:19:06+00:00",
  "fetched_at": "2026-02-11T00:34:18.892628+00:00",
  "category": "macroeconomics_finance",
  "subcategory": null,
  "keywords": [],
  "location": null,
  "raw_data": {
    "title": "CSL Shares Fall 11% After First-Half Net Profit Misses Estimate",
    "description": "CSL Ltd. shares dropped after the Australian biotech posted an 81% drop in first-half profit, as a new interim chief executive officer takes charge amid asset write-downs, weaker vaccine markets and a years-long slide in investor confidence.",
    "url": "https://www.bloomberg.com/news/articles/2026-02-10/csl-first-half-profit-slumps-highlighting-challenge-for-new-ceo",
    "published": "2026-02-10T21:19:06+00:00",
    "source": "Bloomberg Markets"
  }
}